Filters
A 68-year-old female presented to our outpatient clinic with chest pain and dyspnoea in early 2024 and was subsequently diagnosed with obstructive hypertrophic cardiomyopathy (oHCM). She had no family history of HCM and declined genetic testing.
The timing of cardiac arrest does not appear to influence the return of spontaneous circulation (ROSC) rate or 90-day survival, a Singapore study has shown.
In patients with uncontrolled hypertension and cardiometabolic comorbidities, renal denervation appears to improve hepatic steatosis, according to a small study.
Peak oxygen consumption (pVO2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM) is reduced following treatment with the beta-blocker bisoprolol but remains unchanged with the calcium-channel blocker verapamil, reports a study.
In Chinese hypertensive patients, lowering systolic blood pressure (BP) to a target of <120 mm Hg for 3 years appears to have no adverse effect on cognitive function, according to a study.
Community pharmacists can effectively recognize treatment gaps in the use of statin therapy for the prevention of atherosclerotic cardiovascular disease (ASCVD) events, suggests a recent study.
Mental disorders such as anxiety and depression, among others, appear to contribute to an increased risk of acute coronary syndrome (ACS), according to a systematic review and meta-analysis.
Sex differences exist among individuals with hypertension, as women tend to initiate antihypertensive therapy at lower intensities and are less likely to be uptitrated than men, reveals a recent study.
Young women with a history of pre-eclampsia (PE) are at significantly increased cardiovascular risk, and the presence of central adiposity (CA) may worsen their vascular health, according to a study.
Cumulative angiotensin II–stimulating (vs angiotensin II–inhibiting) antihypertensive exposure is associated with lower risk of certain dementia-related neuropathologies, a US study has found.
